gold
nanoparticl
gnp
attract
signific
interest
novel
platform
nanobiotechnolog
biomedicin
conveni
surfac
bioconjug
molecular
remark
properti
recent
publish
exampl
includ
applic
gnp
genom
biosensor
immunoassay
clinic
chemistri
detect
control
microorgan
cancer
cell
photothermolysi
target
deliveri
drug
substanc
optic
imag
monitor
biolog
cell
noteworthi
fact
gnp
increasingli
administ
anim
human
parenter
particular
serv
carrier
deliveri
drug
genet
materi
antigen
colloid
metal
gold
bioinert
name
brown
et
al
gave
articl
stress
import
nanomet
size
biolog
effect
even
seemingli
inert
materi
gold
natur
suppos
first
cell
gnp
encount
way
mammalian
organ
immun
system
particular
phagocyt
link
neutrophil
monocyt
macrophag
dendrit
cell
mast
cell
inde
earli
first
attempt
investig
colloid
gold
biodistribut
perform
found
parenter
administr
colloid
gold
particl
captur
liver
cell
excret
bile
elimin
organ
fece
inject
gold
identifi
mostli
kupffer
cell
perhap
scott
et
al
first
note
phagocytosi
gnp
size
depend
besid
hardonk
et
import
role
kupffer
cell
elimin
gnp
establish
sadauska
et
inject
gnp
intraven
mice
electron
microscopi
show
inject
gnp
accumul
macrophag
liver
spleen
author
conclud
gnp
penetr
phagocyt
primarili
kupffer
cell
liver
subsequ
sadauska
et
al
report
gnp
get
local
lysosom
endosom
kupffer
cell
retain
six
month
influenc
size
solubl
surfac
modif
biocompat
gnp
use
biolog
applic
well
howev
effect
nanoparticl
properti
immun
system
still
explor
review
discuss
select
penetr
gnp
immun
cell
interact
gnp
immun
cell
receptor
review
also
summar
known
applic
gnp
antigen
carrier
adjuv
immun
prepar
antibodi
vivo
immun
system
cell
constitut
first
barrier
nanoparticl
penetr
anim
tissu
cell
therefor
studi
gnp
interact
phagocyt
mechan
intracellular
uptak
respons
immun
cell
gnp
undoubtedli
major
interest
perhap
first
detail
consider
issu
found
shukla
et
use
three
microscop
method
examin
uptak
nm
gnp
macrophag
cell
conclus
studi
small
gnp
enter
macrophag
pinocytosi
get
local
mostli
lysosom
perinuclear
space
whole
shukla
et
al
data
indic
gnp
biocompat
noncytotox
nonimmunogen
suppress
product
reactiv
oxygen
speci
caus
elabor
proinflammatori
cytokin
contradict
data
yen
et
al
contrast
data
shukla
et
yen
et
al
note
administr
gnp
number
macrophag
decreas
size
increas
accompani
elev
product
emphas
data
shukla
et
al
obtain
small
nm
particl
howev
lim
et
use
much
larger
nm
hollow
nsph
cap
dextran
zhang
et
use
nm
gnp
achiev
result
similar
find
shukla
et
al
cell
cultur
sumbayev
et
al
show
citratestabil
gnp
specif
downregul
size
depend
manner
cellular
respons
induc
vitro
vivo
recent
studi
et
al
demonstr
nm
gold
nanoparticl
induc
cell
mediat
respons
accompani
inflammatori
natur
killer
nk
cell
stimul
wherea
nm
gold
nanoparticl
effici
taken
without
induc
dendrit
cell
matur
lymphocyt
prolifer
summar
publish
data
reveal
strong
effect
gnp
size
function
product
proinflammatori
cytokin
inspir
data
gnp
uptak
macrophag
choi
et
al
even
propos
new
method
phototherm
therapi
tumor
employ
trojan
hors
form
monocyt
macrophag
laden
phagocytos
gnss
purpos
dreaden
et
al
suggest
use
gnp
conjug
macrolid
antibiot
accumul
tumorspecif
macrophag
induc
cytotox
caus
tumor
cell
die
thu
particl
size
structur
studi
critic
macrophag
uptak
influenc
colloid
gold
immunocompet
cell
examin
vivo
also
tian
et
al
lou
et
al
particular
inject
nonconjug
gnp
mice
enhanc
prolifer
lymphocyt
normal
killer
well
increas
product
quit
interest
data
acquir
et
al
nm
nonconjug
gnp
result
follow
inde
entri
murin
bone
marrow
macrophag
gnp
affect
product
proinflammatori
cytokin
howev
gnp
surfac
modifi
peptid
agip
amyloid
growth
inhibitori
peptid
lpffd
sap
sweet
arrow
peptid
vrlppp
gnp
entri
macrophag
involv
induct
synthas
proinflammatori
cytokin
addit
inhibit
macrophag
prolifer
recognit
conjug
made
effect
tolllik
receptor
surfac
macrophag
yet
staroverov
et
al
demonstr
nm
nonconjug
gnp
conjug
high
lowmolecularweight
antigen
entri
rat
periton
macrophag
enhanc
respiratori
activ
activ
macrophag
mitochondri
enzym
fig
gnp
also
greatli
increas
product
fig
lee
et
al
report
penetr
gold
nanorod
gnr
gnr
macrophag
induc
releas
inflammatori
mediat
cytokin
prostaglandin
etc
activ
immun
respons
gene
thu
addit
earli
observ
shukla
et
al
bare
gnp
publish
indic
signific
role
surfac
coat
macrophag
respons
gnp
uptak
activ
macrophag
gnp
found
sever
serv
basi
new
vaccin
adjuv
usual
cellular
uptak
immunoact
depend
strongli
particl
size
nm
particl
conjug
disaccharid
perform
far
better
smaller
nm
yet
anoth
mean
activ
macrophag
gnp
propos
wei
et
al
purpos
use
nm
gnp
conjug
cpg
oligodeoxynucleotid
known
oligonucleotid
demethyl
site
microbi
dna
activ
macrophag
immun
respons
interact
receptor
subsequ
trigger
cascad
immun
respons
signal
immunostimul
activ
synthet
oligonucleotid
contain
cpg
motif
may
analog
oligonucleotid
bacteri
accord
wei
et
conjug
effect
enhanc
nanoparticl
intern
macrophag
greatli
increas
secret
proinflammatori
cytokin
nm
conjug
greater
degre
nm
one
immunostimulatori
effect
much
greater
nativ
cpg
concentr
recent
examin
influenc
size
pegyl
gnp
activ
receptor
murin
macrophag
cpg
oligonucleotid
gnp
diamet
nm
inhibit
cpginduc
elabor
activ
receptor
effect
markedli
size
depend
peak
nm
gnp
penetr
cell
intens
massich
et
al
report
immun
respons
macrophag
phagocytosi
gnp
function
polyval
oligonucleotid
effect
uptak
level
interferon
product
found
depend
densiti
dna
molecul
gnp
surfac
kim
et
al
show
uptak
effect
oligonucleotidefunction
gnp
differ
cell
isol
peripher
blood
mononuclear
cell
introduc
cultur
addit
first
type
cell
uptak
gnp
conjug
activ
express
immun
respons
gene
recent
articl
walkey
et
al
describ
thorough
studi
effect
coat
gnp
serum
protein
peg
macrophag
uptak
author
studi
adsorpt
blood
serum
protein
pegcoat
gnp
differ
densiti
peg
coat
increas
peg
coat
densiti
reduc
serum
protein
adsorpt
chang
composit
adsorb
protein
layer
particl
size
also
affect
serum
protein
adsorpt
chang
steric
interact
peg
molecul
densiti
peg
molecul
gnp
surfac
size
gnp
determin
mechan
effect
macrophag
uptak
possibl
composit
adsorb
blood
serum
protein
avail
cell
regul
densiti
peg
coat
lower
peg
molecul
per
macrophag
uptak
gnp
depend
presenc
adsorb
protein
serumdepend
uptak
densiti
higher
peg
molecul
per
serumindepend
uptak
seen
fig
serumdepend
uptak
effect
serumindepend
uptak
appar
differ
energi
interact
interestingli
serumindepend
uptak
effect
larg
gnp
nm
wherea
serumdepend
uptak
maxim
nm
gnp
note
immedi
contact
gnp
blood
lymph
gastric
juic
biolog
liquid
vivo
interact
gnp
solvabl
protein
biomolecul
result
format
protein
corona
similarli
concept
function
gnp
concept
corona
import
tune
surfac
physicochem
properti
gnp
charg
hydrodynam
size
colloid
stabil
fact
corona
form
first
interfac
determin
first
interact
gnp
withor
within
live
cell
corona
dynam
biopolym
layer
strongli
affect
cellular
uptak
owe
modif
particl
properti
overal
size
charg
etc
although
much
plasma
protein
bind
gnp
albumin
apolipoprotein
immunoglobulin
complement
fibrinogen
abundantli
bound
protein
form
corona
intraven
inject
coat
gnp
protein
larg
determin
particl
fate
organ
tissu
cell
effici
cellular
uptak
clearanc
immunolog
properti
et
al
show
gnp
attenu
lpsinduc
product
inhibit
nuclear
pathway
cell
contrast
liu
et
al
demonstr
pegyl
gnp
intern
quickli
lipopolysaccharideactiv
cell
unstimul
cell
reach
satur
within
h
pegyl
gnp
enhanc
lpsinduc
product
induc
nitric
oxid
synthas
express
cell
partli
activ
mitogenactiv
protein
kinas
pathway
goldstein
et
al
show
gnp
plasmon
excit
could
activ
pathway
macrophag
et
al
studi
cellular
uptak
gnp
without
exposur
cell
latrunculin
phagocytosi
inhibitor
result
indic
size
depend
intern
mechan
macrophag
cell
intern
larger
gnp
nm
block
presenc
latrunculin
although
could
attach
cell
membran
smaller
gnp
nm
though
block
actindepend
process
consider
interest
studi
uptak
gnp
macrophag
also
cell
immun
system
particular
dendrit
cell
past
decad
dendrit
cell
attract
increas
interest
owe
eas
isol
peripher
blood
monocyt
abil
effect
present
antigen
cell
great
deal
work
done
modul
immun
respons
patient
chronic
infect
oncolog
diseas
use
antigenprim
dendrit
gnp
name
among
carrier
applic
antigen
deliveri
dendrit
cell
exampl
cheung
et
al
describ
use
nm
gnp
present
peptid
antigen
associ
viru
dendrit
cell
accord
tem
data
peptidefunction
gnp
penetr
dendrit
cell
cytoplasm
found
nuclei
uptak
gnp
dendrit
cell
result
increas
content
present
major
histocompat
complex
mhci
antigen
cell
correspondingli
activ
epitopespecif
immun
respons
cytotox
cell
cruz
et
al
address
dendrit
cell
uptak
immun
respons
activ
nm
gnp
conjug
prostat
cancer
peptid
antigen
tem
lcm
flow
cytometri
gnp
function
peptid
fc
fragment
igg
shown
interact
receptor
dendrit
cell
local
upon
uptak
cytoplasm
diffus
way
intern
antigenconjug
gnp
dendrit
cell
brought
increas
immun
respons
compar
effect
obtain
use
nativ
antigen
manifest
enhanc
lymphocyt
prolifer
approach
author
opinion
open
way
creation
effect
system
develop
antitumor
vaccin
villier
et
al
report
effect
nm
nonantigenfunction
gnp
immun
function
dendrit
cell
find
gnp
enter
cell
endosom
cytotox
effect
product
proinflammatori
cytokin
howev
promot
secret
interleukin
directli
involv
activ
cell
thu
regul
antigenspecif
immun
respons
author
also
note
develop
long
dendrit
increas
cellsurfac
amount
mhcii
molecul
present
antigen
lymphocyt
thu
even
nonfunction
gnp
immunostimulatori
dendrit
cell
ye
et
al
use
tem
flow
fluorocytometri
quantifi
uptak
gnr
dendrit
cell
particl
effect
function
compar
spheric
gnp
gnr
enter
dendrit
cell
effect
induc
higher
express
immunocostimulatori
molecul
characterist
dendrit
cell
lin
et
al
report
gnp
complex
peptid
deriv
tumorassoci
antigen
taken
effect
dendrit
cell
moreov
dendrit
cell
take
gnp
minim
toxic
process
vaccin
peptid
particl
stimul
cytotox
lymphocyt
high
peptid
densiti
gnp
surfac
stimul
cytotox
lymphocyt
better
free
peptid
thu
gnp
great
potenti
carrier
variou
vaccin
type
gnpmediat
respons
dendrit
cell
depend
physicochem
properti
gnp
surfac
exampl
fytiano
et
al
clearli
indic
chemic
composit
surfac
charg
gnp
modul
uptak
dendrit
cell
cytokin
releas
vivo
gnp
effect
dosedepend
particular
demonstr
mice
oral
administ
gnp
show
increas
activ
phagocyt
chang
lymphocyt
phenotyp
ie
increas
percentag
b
doubl
posit
cell
lowest
dose
proinflammatori
immunostimul
effect
enhanc
synthesi
proinflammatori
cytokin
effect
highest
dose
consid
proinflammatori
immunotox
stimul
cytokin
synthesi
accompani
drastic
declin
prolif
activ
lymphocyt
estim
function
impact
gnp
b
lymphocyt
sharma
et
al
treat
murin
b
lymphocyt
cell
line
nm
citratestabil
gnp
treatment
activ
luciferas
report
activ
correl
alter
b
lymphocyt
function
ie
increas
antibodi
express
accord
tem
imag
gnp
could
penetr
cellular
membran
therefor
could
interact
intracellular
compon
signal
pathway
vitro
ex
vivo
vivo
evid
suggest
gnp
activ
b
cell
enhanc
igg
gnp
treatment
upregul
downregul
enhanc
downstream
igg
secret
enhanc
size
time
depend
gnp
rang
nm
maximum
stimulatori
activ
product
antibodi
moreov
gnp
augment
lymphocyt
prolifer
respons
phytohemagglutinin
effect
greater
assynthes
cap
gold
nanoparticl
releas
lymphocyt
increas
effect
mark
assynthes
gnp
cap
bartneck
et
al
report
interact
various
shape
size
particl
gnp
human
neutrophil
granulocyt
monocyt
macrophag
basi
studi
mechan
nanoparticl
trap
classifi
macropinocytosi
rather
phagocytosi
particl
shape
found
affect
strongli
particl
trap
cell
immun
system
specif
ctabcoat
gnr
nm
could
trap
faster
ctabcoat
nm
gold
nanospher
replac
ctab
poli
ethylen
oxid
greatli
reduc
uptak
effect
type
gnp
nanoparticl
uptak
immun
cell
accompani
activ
gene
proinflammatori
cytokin
correspond
chang
cell
phenotyp
characterist
fact
profession
phagocyt
cell
took
gnp
two
order
magnitud
effect
eg
hela
cell
addit
bartneck
et
al
reveal
altern
elimin
mechan
wherebi
gnp
clear
peripher
blood
via
extracellular
network
trap
produc
neutrophil
granulocyt
group
present
uptak
gnp
variou
cell
reticuloendotheli
system
monocyt
macrophag
immatur
matur
dendrit
cell
endotheli
cell
greatest
uptak
abil
demonstr
macrophag
endotheli
cell
immatur
dendrit
cell
posit
charg
gnp
penetr
cell
reticuloendotheli
system
effect
moreov
gnp
intensifi
induct
sever
cytokin
includ
dendrit
cell
macrophag
dendrit
cell
interestingli
matur
dendrit
cell
gnp
accumul
mhcii
compart
consequ
may
affect
antigen
process
thu
gnp
penetr
variou
immun
cell
fig
activ
product
proinflammatori
cytokin
tabl
phagocyt
cell
immun
system
multitud
variou
receptor
surfac
bind
take
foreign
interact
variou
type
receptor
consequ
variou
type
gnp
endocytosi
depend
mani
way
nanoparticl
size
shape
especi
surfac
function
includ
opson
protein
cultur
medium
blood
plasma
presenc
mannosecontain
polysaccharid
gnp
research
inclin
believ
key
role
macrophag
uptak
gnp
play
scaveng
mainli
involv
endocytosi
apoptot
cell
characterist
peculiar
function
contrast
macrophag
receptor
absenc
releas
proinflammatori
cytokin
specif
patel
et
al
demonstr
uptak
gnp
function
polyval
oligonucleotid
mammalian
cell
effect
scaveng
receptor
cell
preincub
fucoidan
polyinosin
acid
agonist
receptor
decreas
uptak
fig
howev
bafilomycin
inhibit
gnp
uptak
pharmacolog
agent
known
inhibit
mode
cellular
entri
coat
gnp
conjug
serum
protein
also
reduc
uptak
effect
indepth
studi
involv
scaveng
receptor
macrophag
uptak
gnp
publish
et
al
data
show
macrophag
take
opson
gnp
srmediat
pathway
nm
gnp
well
clathrin
caveolindepend
pinocytosi
nm
gnp
thu
smaller
nm
particl
use
broader
rang
intern
rout
contrast
larger
nm
gnp
noteworthi
fact
demonstr
inhibit
analysi
phagocytosi
began
interact
gnp
scaveng
receptor
attend
induct
proinflammatori
cytokin
sinc
immunolog
properti
colloid
metal
particular
gold
attract
much
research
interest
interest
mainli
due
physicochem
nonspecif
theori
immun
propos
j
bordet
postul
immunogen
along
antigen
specif
depend
predominantli
physicochem
properti
antigen
first
colloid
state
l
zilber
made
success
attempt
obtain
agglutin
sera
colloid
interestingli
repeat
attempt
prepar
antisera
colloid
gold
perform
almost
year
later
yet
sever
author
shown
introduct
complet
antigen
togeth
colloid
metal
promot
product
furthermor
hapten
may
caus
antibodi
product
adsorb
colloid
numer
data
influenc
colloid
gold
nonspecif
immun
respons
given
one
best
earli
particular
note
h
intraven
inject
ml
colloid
gold
rabbit
sizabl
increas
total
leucocyt
ml
blood
slight
declin
mononuclear
cell
consider
increas
polynuclear
cell
inject
colloid
metal
phenomena
observ
unfortun
advanc
immunolog
denial
mani
postul
bordet
theori
interest
immunolog
properti
colloid
decreas
doubt
though
data
obtain
enhanc
immun
respons
antigen
adsorb
colloid
particl
util
develop
variou
sizedepend
gnpsinduc
chang
increas
decreas
number
white
blood
cell
report
sever
recent
known
antibodi
biosynthesi
induc
substanc
possess
suffici
develop
structur
immunogen
substanc
includ
protein
polysaccharid
synthet
polym
howev
mani
biolog
activ
substanc
vitamin
hormon
antibiot
narcot
etc
rel
small
molecular
mass
rule
elicit
pronounc
immun
respons
standard
method
antibodi
prepar
vivo
limit
overcom
chemic
attach
substanc
hapten
highmolecularweight
carrier
often
protein
make
possibl
obtain
specif
antisera
howev
antisera
usual
contain
attend
antibodi
carrier
antigen
let
us
take
brief
look
two
interrel
problem
current
immunolog
attract
much
research
attent
develop
antibodi
nonimmunogen
lowmolecularweight
compound
hapten
creation
nextgener
vaccin
base
natur
microbi
synthet
known
antibodi
biosynthesi
induc
substanc
possess
suffici
develop
structur
immunogen
substanc
includ
protein
polysaccharid
synthet
howev
mani
biolog
activ
substanc
neurotransmitt
hormon
vitamin
antibiot
etc
rel
small
molecular
mass
lowmolecularweight
antigen
categori
weak
antigen
ie
elicit
pronounc
immun
respons
hapten
weakli
immunogen
choic
optim
carrier
deliveri
system
provid
high
immun
respons
parallel
obtain
pure
enough
antibodi
prepar
import
task
produc
antibodi
lowmolecularweight
compound
tradit
problem
solv
chemic
attach
hapten
protein
matrix
call
schlepper
german
schleppen
drag
use
adjuv
intens
scheme
anim
immun
obtain
bovin
serum
albumin
bsa
ovalbumin
thyreoglobulin
hemocyanin
diphtheria
tetanu
toxoid
case
synthet
peptid
gener
use
schlepper
howev
method
yield
antibodi
hapten
immunodomin
site
carrier
note
carrier
use
pronounc
immun
respons
weak
antigen
alway
develop
besid
subsequ
purif
screen
obtain
antibodi
labori
expens
titr
affin
often
low
current
use
adjuv
base
oil
emuls
suspens
inorgan
substanc
rule
liabl
phase
separ
often
reactogen
immunogen
properti
vari
time
mani
adjuv
caus
local
system
recent
year
effort
made
develop
complex
antigen
ie
artifici
molecular
complex
form
necessari
antigen
carrier
orand
adjuv
particular
synthet
polyelectrolyt
polyllysin
polyacryl
acid
polyvinylpyridin
sulfon
polystyren
ficol
etc
propos
use
polym
compound
produc
chainrad
polymer
correspond
monom
simplic
polyelectrolyt
composit
synthesi
possibl
obtain
polym
chain
wide
rang
molecular
mass
ie
variou
length
solubl
water
properti
capac
conform
transit
format
complex
protein
etc
open
possibl
use
polyelectrolyt
immunolog
investig
adjuv
carrier
capabl
antigen
deposit
site
inject
enhanc
antigen
present
immunocompet
cell
induct
product
necessari
cytokin
howev
low
immunogen
complex
due
small
epitop
densiti
prompt
research
look
new
nontox
effect
carrier
addit
possess
adjuv
properti
respect
special
interest
nanoscal
corpuscular
carrier
polym
nanoparticl
eg
made
polymethylmethacryl
polyalkylcyanoacryl
polylactidecoglycolid
poli
acid
polystyren
etc
liposom
proteasom
microcapsul
fulleren
carbon
nanotub
graphen
oxid
dendrim
paramagnet
particl
silica
nanoparticl
titanium
dioxid
nanoparticl
aluminum
aluminum
oxid
nanoparticl
cobalt
oxid
nanoparticl
silver
nanoparticl
selenium
nanoparticl
other
use
form
manifest
immunogen
given
substanc
host
immun
system
vari
antigen
adsorb
encapsul
nanoparticl
may
use
adjuv
optim
immun
respons
japanes
first
report
success
gener
antibodi
glutam
use
colloid
gold
particl
carrier
subsequ
number
paper
publish
whose
author
appli
develop
techniqu
obtain
antibodi
follow
hapten
complet
antigen
amino
acid
plateletactiv
factor
quinolin
acid
biotin
recombin
peptid
lysophosphatid
acid
endostatin
capsid
peptid
hepat
footandmouth
virus
peptid
actin
antibiot
ivermectin
azobenzen
clenbuterol
racemas
listeria
escherichia
coli
surfac
antigen
neisseria
streptococcu
burkholderia
mallei
carbohydr
antigen
pseudomona
aeruginosa
flagellin
transmiss
gastroenter
viru
tuberculin
peptid
malaria
plasmodium
surfac
protein
opisthorchiasi
antigen
tetanu
studi
hapten
complet
antigen
directli
conjug
colloid
gold
particl
mix
complet
freund
adjuv
alum
use
anim
immun
result
hightit
antisera
obtain
need
purif
contamin
antibodi
fig
thu
date
almost
public
demonstr
success
applic
function
gnp
obtain
antibodi
differ
antigen
case
applic
gnp
conjug
produc
higher
titer
affin
often
level
specif
antibodi
produc
immun
anim
gold
nanoparticl
conjug
antigen
higher
gener
classic
adjuv
amount
antigen
requir
achiev
respons
order
magnitud
lower
immun
standard
reason
may
due
greater
accumul
antigen
cell
dendrit
cell
allow
greater
present
therapeut
antigen
immun
system
reader
find
similar
consider
sever
studi
adjuv
properti
gnp
although
uniqu
exampl
suffici
consid
signific
massiv
collect
experiment
data
use
antituberculin
antibodi
immunoassay
mycobacteria
describ
first
time
ref
fig
illustr
applic
immunodot
assay
tem
light
microscopi
imag
mycobacteria
reaction
product
visual
use
immunogold
marker
futur
work
author
plan
use
gnp
tuberculin
conjug
obtain
diagnost
antibodi
also
develop
tuberculinbas
antituberculosi
vaccin
consid
new
variant
theranost
call
prophynost
prophylax
diagnost
pow
suggest
attach
hapten
acid
carrier
protein
conjug
complex
colloid
gold
suggest
support
paper
devot
rais
antibodi
amino
antibodi
obtain
way
possess
high
specif
antigen
studi
higher
pow
put
extrem
high
titer
compar
antibodi
produc
routin
present
australianbas
compani
immunosolut
offer
antibodi
obtain
accord
ref
neurotransmitt
amino
acid
demenev
et
al
show
first
time
possibl
use
colloid
gold
particl
part
antivir
vaccin
carrier
protein
antigen
tickborn
enceph
viru
capsid
accord
author
data
offer
experiment
vaccin
higher
protect
properti
commerci
analog
despit
fact
vaccin
contain
adjuv
subsequ
gnp
use
gener
antibodi
design
experiment
vaccin
peptid
carbohydr
influenza
west
nile
respiratori
syncyti
hepat
e
well
addit
gnp
use
develop
experiment
vaccin
wang
et
al
suggest
new
therapeut
vaccin
base
combin
myelinassoci
inhibitor
gnp
treatment
rat
medullispin
trauma
also
gnpassist
antigen
sever
group
report
new
administr
way
oral
pulmonari
transcutan
transmucos
tabl
summar
literatur
data
antigen
hapten
conjug
gnp
carrier
use
immun
anim
titer
antibodi
increas
owe
gnp
consider
number
paper
devot
use
gnp
creat
dna
vaccin
emerg
well
principl
dna
immun
follow
gene
construct
code
protein
one
need
obtain
antibodi
introduc
organ
gene
express
effect
protein
serv
antigen
develop
immun
earli
paper
immun
conduct
subcutan
intramuscular
inject
nake
dna
howev
purpos
biolist
transfect
use
gnp
began
appli
almost
simultan
found
effect
appar
multipl
site
transgen
interact
tissu
transgen
penetr
directli
cell
method
gene
immun
often
call
dna
vaccin
welldevelop
experi
anim
shown
high
effici
especi
respect
viral
infect
tickborn
enceph
hiv
infect
hepat
b
dna
immun
advantag
routin
vaccin
singl
recombin
vector
govern
synthesi
sever
antigen
simultan
reduc
number
separ
immun
result
eras
problem
connect
difficulti
protein
penetr
organ
reduc
significantli
risk
side
effect
depend
toxic
contamin
protein
introduc
routin
immun
virul
bacteria
virus
use
one
expect
dna
immun
among
effect
genetherapi
method
come
recent
intramuscular
inject
nake
dna
abandon
dna
vaccin
investig
come
use
nanoparticl
carrier
genet
materi
introduc
inject
substanc
subcutan
intracutan
epicutan
among
nanoparticl
use
dna
carrier
gnp
spheric
cylindr
multival
nanorod
especi
popular
besid
dna
polysaccharid
peptid
glycopeptid
use
vector
moreov
wherea
gold
earlier
use
carrier
zhao
et
al
note
although
mechan
behind
well
understood
appear
gold
cartridg
might
enhanc
immun
respons
vivo
dykman
et
al
propos
technolog
prepar
antibodi
variou
antigen
use
colloid
gold
carrier
adjuv
method
antigen
adsorb
directli
gnp
surfac
crosslink
reagent
found
anim
immun
colloid
conjug
without
use
freund
complet
adjuv
yield
specif
hightit
antibodi
varieti
antigen
concomit
antibodi
gnp
stimul
antibodi
synthesi
rabbit
rat
mice
amount
antigen
requir
reduc
compar
need
convent
adjuv
tabl
summari
experiment
result
give
ground
state
use
method
gold
immun
one
obtain
antibodi
hapten
difficult
obtain
antibodi
convent
particular
sever
antibiot
vitamin
nonimmunogen
peptid
amount
antigen
use
immun
case
much
smaller
use
convent
method
even
latter
allow
one
obtain
immun
respons
experi
sever
antigen
conjug
gnp
immun
respons
obtain
without
use
adjuv
gnp
use
antigen
carrier
stimul
phagocyt
activ
lymphoid
cell
induc
releas
inflammatori
mediat
fact
show
decis
gnp
possess
adjuv
properti
use
gnp
antigen
carrier
activ
phagocyt
activ
macrophag
influenc
function
lymphocyt
see
appar
may
respons
immunomodul
effect
also
found
gnp
conjug
low
highmolecular
weight
antigen
stimul
respiratori
activ
cell
reticuloendotheli
system
activ
macrophag
mitochondri
possibl
determin
adjuv
properti
colloid
gold
gnp
act
adjuv
carrier
ie
present
hapten
cell
seem
interest
aspect
manifest
immunogen
properti
colloid
gold
particular
gnp
conjug
antigen
found
influenc
activ
cell
tenfold
increas
prolifer
compar
observ
addit
nativ
antigen
found
fact
show
fundament
possibl
target
activ
cell
follow
macrophag
activ
pathogen
kill
sever
author
report
success
therapi
rheumatoid
arthriti
colloid
gold
accord
data
effect
gnp
case
inhibit
monocyteinduc
lymphocyt
prolifer
transform
au
au
immunesystem
cell
action
sever
amino
acid
discuss
note
inject
gnp
laboratori
anim
could
result
inflammatori
respons
accumul
gold
reticular
cell
lymphoid
tissu
activ
cellular
humor
immun
howev
singl
paper
avail
us
report
data
mechan
properti
gold
particl
opinion
reason
given
pow
prefer
macrophag
respons
corpuscular
antigen
oppos
solubl
one
certainli
valid
fact
also
confirm
research
studi
mechan
action
dna
vaccin
use
gold
particl
deliv
genet
materi
role
kupffer
langerhan
cell
develop
immun
respons
shown
investig
influenc
dendrit
cell
develop
immun
respons
upon
inject
gnpconjug
antigen
discuss
vallhov
et
al
addit
author
note
use
nanoparticl
medic
practic
one
ensur
lipopolysaccharid
surfac
similar
result
interact
gnp
macrophag
report
kingston
et
al
interact
cell
immun
system
gnp
activ
examin
dobrovolskaia
accord
nanoimmunolog
new
promis
rapidli
develop
field
spite
mani
obstacl
signific
progress
understand
nanoparticl
interact
compon
immun
system
achiev
howev
much
yet
studi
understood
modern
trend
use
gnp
vaccin
applic
multival
peptid
combin
use
gnp
immunostimul
particular
cpg
includ
conjug
gnp
polyval
nucleic
plant
adjuv
eg
extract
quillaja
asparagu
racemosu
tamarindu
indica
applic
gnp
variou
size
shape
includ
nanorod
nanocub
nanocag
nanoclust
howev
data
answer
question
mechan
antigen
present
helper
accord
current
present
antigen
cell
preced
process
ie
cleavag
peptid
fragment
follow
format
bond
molecul
major
histocompat
complex
transport
antigen
fragment
surfac
antigenpres
cell
remain
unclear
process
proceed
hapten
hypothesi
multival
antigen
ie
antigen
form
high
local
concentr
unival
antigen
surfac
gold
particl
answer
question
either
hypothet
mechan
immunomodulatori
effect
nanoparticl
shown
fig
recent
mani
paper
publish
problem
associ
gnp
use
target
drug
deliveri
discuss
opinion
one
deal
question
care
take
account
possibl
product
anim
human
antibodi
specif
administ
drug
adsorb
gold
particl
believ
discoveri
adjuv
properti
gnp
creat
favor
condit
design
nextgener
vaccin
alongsid
gnp
nonmetal
nanoparticl
also
serv
antigen
carrier
publish
exampl
includ
liposom
proteosom
microcapsul
fulleren
carbon
nanotub
dendrim
paramagnet
view
especi
promis
carrier
synthet
natur
polymer
biodegrad
nanomateri
polymethyl
methacryl
poli
lactidecoglycolid
acid
chitosan
gelatin
use
nanoparticl
immunogen
load
substanc
represent
host
immun
system
chang
nanoparticl
conjug
absorb
capsul
antigen
serv
adjuv
optim
immun
respons
vaccin
evid
advantag
biodegrad
nanoparticl
complet
util
vaccin
organ
high
load
effici
target
substanc
enhanc
abil
cross
variou
physiolog
barrier
low
system
side
effect
likelihood
immun
action
biodegrad
nanoparticl
gnp
corpuscular
carrier
similar
keep
mind
recent
data
low
toxic
gnp
effici
excret
hepatobiliari
system
expect
nanoparticl
class
gnp
biodegrad
nanoparticl
compet
equal
foot
develop
nextgener
vaccin
thu
gnp
uptak
cell
immun
system
activ
product
proinflammatori
cytokin
find
indic
directli
gnp
immunostimulatori
activ
immun
cell
gnp
shown
sever
author
may
serv
basi
develop
new
vaccin
adjuv
case
usual
cell
interact
variou
type
receptor
surfac
immun
cell
correspondingli
variou
type
gnp
endocytosi
depend
larg
surfac
function
gnp
mani
research
believ
key
role
macrophag
uptak
gnp
play
scaveng
receptor
howev
interact
function
gnp
cell
immun
system
still
far
understood
less
detail
requir
conclus
may
said
time
probabl
right
talk
biochemistri
also
biophys
immun
respons
uniqu
biophys
properti
metal
particular
surfac
charg
electrostat
field
particl
influenc
certain
manner
charg
orient
polar
antigen
molecul
adsorb
particl
significantli
affect
immunerespons
process
thu
gnp
serv
adjuv
improv
effect
vaccin
stimul
antigenpres
cell
provid
control
releas
antigen
addit
immunogen
cnp
determin
physicochem
properti
particl
size
shape
charg
surfac
function
studi
immun
respons
characterist
use
gnp
carrier
adjuv
product
antibodi
allow
evalu
potenti
develop
effect
vaccin
